BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

235 related articles for article (PubMed ID: 22990803)

  • 1. Induction of anti-Plasmodium immunity following subpatent infection with live erythrocytic stages and drug cure.
    Stanisic DI; Good MF
    Methods Mol Biol; 2013; 923():535-47. PubMed ID: 22990803
    [TBL] [Abstract][Full Text] [Related]  

  • 2. That was then but this is now: malaria research in the time of an eradication agenda.
    Kappe SH; Vaughan AM; Boddey JA; Cowman AF
    Science; 2010 May; 328(5980):862-6. PubMed ID: 20466924
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The species specificity of immunity generated by live whole organism immunisation with erythrocytic and pre-erythrocytic stages of rodent malaria parasites and implications for vaccine development.
    Inoue M; Tang J; Miyakoda M; Kaneko O; Yui K; Culleton R
    Int J Parasitol; 2012 Aug; 42(9):859-70. PubMed ID: 22846785
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The immunological challenge to developing a vaccine to the blood stages of malaria parasites.
    Good MF; Stanisic D; Xu H; Elliott S; Wykes M
    Immunol Rev; 2004 Oct; 201():254-67. PubMed ID: 15361246
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Evidences of protection against blood-stage infection of Plasmodium falciparum by the novel protein vaccine SE36.
    Horii T; Shirai H; Jie L; Ishii KJ; Palacpac NQ; Tougan T; Hato M; Ohta N; Bobogare A; Arakaki N; Matsumoto Y; Namazue J; Ishikawa T; Ueda S; Takahashi M
    Parasitol Int; 2010 Sep; 59(3):380-6. PubMed ID: 20493274
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The importance of the spleen in malaria.
    Engwerda CR; Beattie L; Amante FH
    Trends Parasitol; 2005 Feb; 21(2):75-80. PubMed ID: 15664530
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The Plasmodium sporozoite survives RTS,S vaccination.
    Snounou G; Grüner AC; Müller-Graf CD; Mazier D; Rénia L
    Trends Parasitol; 2005 Oct; 21(10):456-61. PubMed ID: 16109504
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Advances in vaccine development against the pre-erythrocytic stage of Plasmodium falciparum malaria.
    Walther M
    Expert Rev Vaccines; 2006 Feb; 5(1):81-93. PubMed ID: 16451110
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The whole parasite, pre-erythrocytic stage approach to malaria vaccine development: a review.
    Epstein JE; Richie TL
    Curr Opin Infect Dis; 2013 Oct; 26(5):420-8. PubMed ID: 23982233
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Erythrocyte and reticulocyte binding-like proteins of Plasmodium falciparum.
    Tham WH; Healer J; Cowman AF
    Trends Parasitol; 2012 Jan; 28(1):23-30. PubMed ID: 22178537
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Empowering malaria vaccination by drug administration.
    Sauerwein RW; Bijker EM; Richie TL
    Curr Opin Immunol; 2010 Jun; 22(3):367-73. PubMed ID: 20434895
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Plasmodium falciparum pre-erythrocytic stage vaccine development.
    Molina-Franky J; Cuy-Chaparro L; Camargo A; Reyes C; Gómez M; Salamanca DR; Patarroyo MA; Patarroyo ME
    Malar J; 2020 Feb; 19(1):56. PubMed ID: 32013956
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pre-erythrocytic malaria vaccines to prevent Plasmodium falciparum malaria.
    Ballou WR; Kester KE; Heppner DG
    Chem Immunol; 2002; 80():253-61. PubMed ID: 12058643
    [No Abstract]   [Full Text] [Related]  

  • 14. Detection of CD4+CD45RO+ T lymphocytes producing IL-4 in response to antigens on Plasmodium falciparum erythrocytes: an in vitro correlate of protective immunity induced with attenuated Plasmodium falciparum sporozoites.
    Bergmann ES; Ballou RW; Krzych U
    Cell Immunol; 1997 Sep; 180(2):143-52. PubMed ID: 9341744
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Malaria blood-stage infection and its control by the immune system.
    Perlmann P; Troye-Blomberg M
    Folia Biol (Praha); 2000; 46(6):210-8. PubMed ID: 11140853
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Pre-erythrocytic malaria vaccines: towards greater efficacy.
    Hill AV
    Nat Rev Immunol; 2006 Jan; 6(1):21-32. PubMed ID: 16493425
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Comparative efficacy of pre-erythrocytic whole organism vaccine strategies against the malaria parasite.
    Friesen J; Matuschewski K
    Vaccine; 2011 Sep; 29(40):7002-8. PubMed ID: 21787828
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The Delay in the Licensing of Protozoal Vaccines: A Comparative History.
    Palatnik-de-Sousa CB; Nico D
    Front Immunol; 2020; 11():204. PubMed ID: 32210953
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Protection against a malaria challenge by sporozoite inoculation.
    Roestenberg M; McCall M; Hopman J; Wiersma J; Luty AJ; van Gemert GJ; van de Vegte-Bolmer M; van Schaijk B; Teelen K; Arens T; Spaarman L; de Mast Q; Roeffen W; Snounou G; Rénia L; van der Ven A; Hermsen CC; Sauerwein R
    N Engl J Med; 2009 Jul; 361(5):468-77. PubMed ID: 19641203
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Functional analysis of Plasmodium falciparum merozoite antigens: implications for erythrocyte invasion and vaccine development.
    Cowman AF; Baldi DL; Duraisingh M; Healer J; Mills KE; O'Donnell RA; Thompson J; Triglia T; Wickham ME; Crabb BS
    Philos Trans R Soc Lond B Biol Sci; 2002 Jan; 357(1417):25-33. PubMed ID: 11839179
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.